Pure Global

Londo-Direct bilirubin reagent - Taiwan Registration be580e4150f6d20222388f0aaf1ec96d

Access comprehensive regulatory information for Londo-Direct bilirubin reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number be580e4150f6d20222388f0aaf1ec96d and manufactured by RANDOX LABORATORIES LTD. The authorized representative in Taiwan is EUGENE-CHEN CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
be580e4150f6d20222388f0aaf1ec96d
Registration Details
Taiwan FDA Registration: be580e4150f6d20222388f0aaf1ec96d
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Londo-Direct bilirubin reagent
TW: ๅ€ซๅคš-็›ดๆŽฅ่†ฝ็ด…็ด ่ฉฆๅŠ‘
Risk Class 2
Cancelled

Registration Details

be580e4150f6d20222388f0aaf1ec96d

DHA00601619307

Company Information

United Kingdom

Product Details

Quantify the total amount of red in serum and blood.

A Clinical chemistry and clinical toxicology

A.1110 Bilirubin (total or direct) test system

import

Dates and Status

Mar 22, 2006

Mar 22, 2011

Oct 13, 2011

Cancellation Information

Logged out

่จฑๅฏ่ญ‰ๅทฒ้€พๆœ‰ๆ•ˆๆœŸ